Cardiac-specific nucleic acid regulatory elements and methods and use thereof
AssigneesVib Vzw, Life Sciences Research Partners VZW, Universiteit Gent
InventorsLay Khim Chuah, Thierry Vandendriessche, Pieter De Bleser
Life of this patent
Estimating the term…
Abstract
The present invention relates to nucleic acid regulatory elements that are able to enhance cardiac-specific expression of genes, methods employing these regulatory elements and uses of these elements. Expression cassettes and vectors containing these nucleic acid regulatory elements are also disclosed. The present invention is particularly useful for applications using gene therapy.
Claims22
A nucleic acid regulatory element of 600 nucleotides or less for enhancing cardiac-specific gene expression, said nucleic acid regulatory element comprising a molecule selected from the group consisting of:
- SEQ ID NO:
- 1, SEQ ID NO:
- 2, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, a molecule having 95% sequence identity to any of these molecules, and a functional fragment of any thereof.
A nucleic acid regulatory element of 600 nucleotides or less hybridizing under stringent conditions to a nucleic acid regulatory element of 600 nucleotides or less comprising a molecule selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 2, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, a molecule having 95% sequence identity to any of these molecules, and a functional fragment of any thereof or to its complement.
(canceled)
Dependencies are inferred from the claim text.